700 patients110,866 observations180 daysLIVE

Patient P-02521

Synthetic patientMETA-24 · Day 174 · 55–64 · M · baseline S14Open companion preview
Therapy response
Declining
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
68%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S14
  2. Day 128 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 128.

Primary contributors, last 14 days
  • GI instability-4
  • Nutritional resilience+3
  • Inflammatory activity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    72%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 88% showed improvement
    • median effect visible after 8 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling 70
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 62
    • Butyrate / short-chain fatty acid production 55
      • MicrobiomeButyrate capacity 41/100
      • Daily logFibre intake low in recent food logs
    • Mucosal barrier integrity 50
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • Daily logGI symptom score 62 and rising
    • Drug metabolism and exposure 20
      • BloodToxicity index 51
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.7 · butyrate capacity 41/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    39 ms
    Sleep
    6.6 h
    Steps
    5,061
    Resting HR
    68 bpm
    Daily log: GI score 62, nutritional resilience 35, adherence 67.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0204820%S0277
    P-0211522%S14GI-04improved75
    P-0238819%S1175
    P-0257523%S14ME-01improved73
    P-0240319%S0371
    P-0233519%S0470
    P-0255020%S0170
    P-0219219%S0569
    P-0265925%S0969
    P-0235619%S0869
    P-0229319%S15HY-01no change68
    P-0259140%S1368